ATYR

Atyr Pharma Inc

• Benzinga·09/24 17:31

  Positive FDA Alignment Boosts ATyr Pharma's Rare Lung Disease

• TipRanks·09/24 15:49

  Why is aTyr Pharma Stock (ATYR) Down 7% Today?

• TipRanks·09/24 15:21

  Analysts Offer Insights on Healthcare Companies: Aytu BioScience (AYTU), Surrozen (SRZN) and aTyr Pharma (ATYR)

• NASDAQ·09/24 14:21

  ATYR Stock In Focus After FDA Alignment On Efzofitimod Phase 3

• TipRanks·09/24 13:41

  aTyr Pharma Aligns with FDA on Efzofitimod Phase 3

• Benzinga·09/24 10:07

  aTyr Pharma Reaches FDA Alignment On Protocol For A Phase 3 Study Of Its Lead Therapeutic Candidate Efzofitimod In Patients With Chronic, Symptomatic Pulmonary Sarcoidosis With Restrictive Lung Disease; Expects To Initiate Study-Related Activities In Q4 2026

• NASDAQ·09/02 10:24

  ATyr Provides Tentative FDA Timeline For Phase 3 Efzofitimod In Lung Disease

• NASDAQ·09/02 02:40

  6 After-Hours Healthcare Gainers: Universe Pharma, BioAffinity, Modular Medical, Telix Pharma & More

• Benzinga·09/01 20:37

  aTyr Pharma Announces It Expects FDA Response Regarding Its Submitted Protocol For Phase 3 Trial Of Efzofitimod To Treat Pulmonary Sarcoidosis With Restrictive Lung Disease In Mid-September

• NASDAQ·08/15 06:59

  Weekly Buzz: LNTH, CBLL Win FDA Nod; AURA Cuts Jobs; TDY Buys VREX; CGEM, DFTX Meet Trial Goals

• TipRanks·08/11 10:56

  aTyr Pharma (ATYR) Receives a Hold from Wells Fargo

• TipRanks·08/10 14:01

  Analysts’ Opinions Are Mixed on These Healthcare Stocks: Embecta Corporation (EMBC) and aTyr Pharma (ATYR)

• TipRanks·08/10 11:25

  RBC Capital Sticks to Their Hold Rating for aTyr Pharma (ATYR)

• TipRanks·08/10 10:30

  Analysts Offer Insights on Healthcare Companies: Aligos Therapeutics (ALGS), aTyr Pharma (ATYR) and Prime Medicine, Inc. (PRME)

• NASDAQ·08/10 07:45

  ATyr Pharma Q2 Net Loss Narrows; Cuts Workforce By 60% To Advance Efzofitimod Into Phase 3